484 related articles for article (PubMed ID: 34518209)
21. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
[TBL] [Abstract][Full Text] [Related]
22. Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
Disoma C; Zhou Y; Li S; Peng J; Xia Z
Biochimie; 2022 Apr; 195():39-53. PubMed ID: 35066101
[TBL] [Abstract][Full Text] [Related]
23. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
24. WNT/β-catenin signaling in the development of liver cancers.
He S; Tang S
Biomed Pharmacother; 2020 Dec; 132():110851. PubMed ID: 33080466
[TBL] [Abstract][Full Text] [Related]
25. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
26. Extrinsic control of Wnt signaling in the intestine.
Koch S
Differentiation; 2017; 97():1-8. PubMed ID: 28802143
[TBL] [Abstract][Full Text] [Related]
27. An oncolytic adenovirus delivering TSLC1 inhibits Wnt signaling pathway and tumor growth in SMMC-7721 xenograft mice model.
Wang Y; Huang P; Hu Y; Guo K; Jia X; Huang B; Liu X; He X; Huang F
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):766-774. PubMed ID: 33928346
[TBL] [Abstract][Full Text] [Related]
28. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders.
Caspi M; Wittenstein A; Kazelnik M; Shor-Nareznoy Y; Rosin-Arbesfeld R
Adv Drug Deliv Rev; 2021 Feb; 169():118-136. PubMed ID: 33346022
[TBL] [Abstract][Full Text] [Related]
30. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
[TBL] [Abstract][Full Text] [Related]
31. The Wnt signaling pathway: a potential therapeutic target against cancer.
Ghosh N; Hossain U; Mandal A; Sil PC
Ann N Y Acad Sci; 2019 May; 1443(1):54-74. PubMed ID: 31017675
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic regulation of the Hedgehog and Wnt pathways in cancer.
Wils LJ; Bijlsma MF
Crit Rev Oncol Hematol; 2018 Jan; 121():23-44. PubMed ID: 29279097
[TBL] [Abstract][Full Text] [Related]
33. Wnt signaling as potential therapeutic target in lung cancer.
Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
[TBL] [Abstract][Full Text] [Related]
34. The Protein Kinase Activity of NME7 Activates Wnt/β-Catenin Signaling to Promote One-Carbon Metabolism in Hepatocellular Carcinoma.
Ren X; Rong Z; Liu X; Gao J; Xu X; Zi Y; Mu Y; Guan Y; Cao Z; Zhang Y; Zeng Z; Fan Q; Wang X; Pei Q; Wang X; Xin H; Li Z; Nie Y; Qiu Z; Li N; Sun L; Deng Y
Cancer Res; 2022 Jan; 82(1):60-74. PubMed ID: 34764205
[TBL] [Abstract][Full Text] [Related]
35. Unlocking the Wnt pathway: Therapeutic potential of selective targeting FZD
Larasati Y; Boudou C; Koval A; Katanaev VL
Drug Discov Today; 2022 Mar; 27(3):777-792. PubMed ID: 34915171
[TBL] [Abstract][Full Text] [Related]
36. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells.
Benoit YD; Guezguez B; Boyd AL; Bhatia M
Clin Cancer Res; 2014 Nov; 20(21):5372-8. PubMed ID: 25006223
[TBL] [Abstract][Full Text] [Related]
38. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
Nguyen VHL; Hough R; Bernaudo S; Peng C
J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
[TBL] [Abstract][Full Text] [Related]
39. WNT Signaling in Cutaneous Squamous Cell Carcinoma: A Future Treatment Strategy?
Sherwood V; Leigh IM
J Invest Dermatol; 2016 Sep; 136(9):1760-1767. PubMed ID: 27448706
[TBL] [Abstract][Full Text] [Related]
40. WNT Signaling as a Therapeutic Target for Glioblastoma.
Latour M; Her NG; Kesari S; Nurmemmedov E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
